Accuray Incorporated

ARAYNASDAQ • USD
2.80 USD
↘ 0.28 (9.09%)AT CLOSE (03:59 PM EST)
3.17
↗ 0.37 (13.25%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
3.17
↗ 0.37 (13.25%)
🔴Market: CLOSED

Shares of Accuray Incorporated (ARAY) are trading at $2.80. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 13, 2026.

Open?$3.08
High?$3.08
Low?$2.75
Prev. Close?$3.08
Volume?140.6K
Avg. Volume?1.8M
VWAP?$2.82
Rel. Volume?0.08x
Bid / Ask
Bid?$2.75 × 200
Ask?$3.59 × 100
Spread?$0.84
Midpoint?$3.17
Valuation & Ratios
Market Cap?8.4M
Shares Out?N/A
Float?86.2M
Float %?72.1%
P/E Ratio?N/A
P/B Ratio?0.16
EPS?-$5.79
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.
Employees
809
Market Cap
9.2M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2007-02-08
Address
1240 DEMING WAY
MADISON, WI 53717
Phone: 608-824-2800
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
1
Momentum?
92
Short Sent.?
50
Piotroski F-Score?5/9Mixed
Altman Z-Score?-1.12Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.51%Elevated
Short Interest?5.6M
Days to Cover?2.9
Free Float86.2M
Avg Daily Volume2.0M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.56Adequate
Quick Ratio?0.71Weak
Cash Ratio?0.25Low
Debt/Equity?1.91High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.16CHEAP▾
P/S?
Peers
100
S&P
97
0.02CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
70
11.7CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.17CHEAP▾
Returns & Efficiency
ROE?
S&P
6
-32.7%WEAK▾
ROA?
S&P
3
-4.5%WEAK▾
Cash Flow & Enterprise
FCF?$-25134000
Enterprise Value?$67.8M
Fundamentals ratios updated end of day